About GevRx Nutraceuticals
GevRx Nutraceuticals is a private company based in Staten Island, New York, incorporated in 2026 in Delaware. It has reported $300,000 raised in one offering on Form D since September 2026. Its chief executive is Douglas Spiel, M.D..
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Sep 18, 2026 | $300,000of $3.0M target | 1 | $300K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on GevRx Nutraceuticals's Form D filed Sep 18, 2026.
DS
Dylan Spiel
Vice President
JC
James Christopher
President, Secretary and Treasurer, director
DD
Douglas Spiel, M.D.
Chief Executive Officer and Chief Medical Director
MD
Michael Betley, Ph.D.
Chief Scientific Officer
ME
Mary Esposito
Director